Host transcriptional response to Ebola virus infection

Vaccines

Volumn 5, Issue 3, 2017, Pages

  Speranza, Emily ^a   Connor, John H ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

Ebola virus disease; Host response; Immune response; Microarray; RNA Seq; Transcriptomic

Indexed keywords

CELLULAR STRESS RESPONSE; EBOLA HEMORRHAGIC FEVER; GENETIC TRANSCRIPTION; HUMAN; IMMORTALIZED CELL LINE; IMMUNE RESPONSE; MICROARRAY ANALYSIS; NEXT GENERATION SEQUENCING; NONHUMAN; REVIEW; RNA SEQUENCE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

EID: 85031094295     PISSN: None     EISSN: 2076393X     Source Type: Journal    
DOI: 10.3390/vaccines5030030     Document Type: Review

References (93)

1. Feldmann, H.; Geisbert, T.W. Ebola haemorrhagic fever. Lancet 2011.
2. Laupland, K.B.; Valiquette, L. Ebola virus disease. Can. J. Infect. Dis. Med. Microbiol. 2014, 25, 128-129.
3. CDC. 2014 Ebola Outbreak in West Africa: Case Counts. Centers for Disease Control and Prevention. Available online: http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/case-counts.html (accessed on 1 June 2017).
4. Geisbert, T.W.; Hensley, L.E.; Larsen, T.; Young, H.A.; Reed, D.S.; Geisbert, J.B.; Scott, D.P.; Kagan, E.; Jahrling, P.B.; Davis, K.J. Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques. Am. J. Pathol. 2003, 163, 2347-2370.
5. Lüdtke, A.; Ruibal, P.; Wozniak, D.M.; Pallasch, E.; Wurr, S.; Bockholt, S.; Gómez-Medina, S.; Qiu, X.; Kobinger, G.P.; Rodríguez, E.; et al. Ebola virus infection kinetics in chimeric mice reveal a key role of T cells as barriers for virus dissemination. Sci. Rep. 2017.
6. Vernet, M.-A.; Reynard, S.; Fizet, A.; Schaeffer, J.; Pannetier, D.; Guedj, J.; Rives, M.; Georges, N.; Garcia-Bonnet, N.; Sylla, A.I.; et al. Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea. JCI Insight 2017, 2, e88864.
7. Bosio, C.M.; Aman, M.J.; Grogan, C.; Hogan, R.; Ruthel, G.; Negley, D.; Mohamadzadeh, M.; Bavari, S.; Schmaljohn, A. Ebola and Marburg Viruses Replicate in Monocyte-Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation. J. Infect. Dis. 2003, 188, 1630-1638.
8. Bray, M.; Geisbert, T.W. Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int. J. Biochem. Cell Biol. 2005, 37, 1560-1566.
9. Ruibal, P.; Oestereich, L.; Lüdtke, A.; Becker-Ziaja, B.; Wozniak, D.M.; Kerber, R.; Korva, M.; Cabeza-Cabrerizo, M.; Bore, J.A.; Koundouno, F.R.; et al. Unique human immune signature of Ebola virus disease in Guinea. Nature 2016, 533, 100-104.
10. Bradfute, S.B.; Braun, D.R.; Shamblin, J.D.; Geisbert, J.B.; Paragas, J.; Garrison, A.; Hensley, L.E.; Geisbert, T.W. Lymphocyte Death in a Mouse Model of Ebola Virus Infection EBOV infection in humans results in mortality rates. J. Infect. Dis. 2007, 196, 296-304.
11. Reed, D.S.; Hensley, L.E.; Geisbert, J.B.; Jahrling, P.B.; Geisbert, T.W. Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques. Viral Immunol. 2004, 17, 390-400.
12. McElroy, A.K.; Erickson, B.R.; Flietstra, T.D.; Rollin, P.E.; Nichol, S.T.; Towner, J.S.; Spiropoulou, C.F. Ebola Hemorrhagic Fever: Novel Biomarker Correlates of Clinical Outcome. J. Infect. Dis. 2014, 210, 558-566.
13. Baize, S.; Leroy, E.M.; Georges, A.J.; Georges-Courbot, M.-C.; Capron, M.; Bedjabaga, I.; Lansoud-Soukate, J.; Mavoungou, E. Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 2002, 128, 163-168.
14. Bixler, S.L.; Goff, A.J. The Role of Cytokines and Chemokines in Filovirus Infection. Viruses 2015, 7, 5489-5507.
15. Wauquier, N.; Becquart, P.; Padilla, C.; Baize, S.; Leroy, E.M. Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis. PLoS Negl. Trop. Dis. 2010, 4, e837.
16. Rougeron, V.; Feldmann, H.; Grard, G.; Becker, S.; Leroy, E.M. Ebola and Marburg haemorrhagic fever. J. Clin. Virol. 2015, 64, 111-119.
17. Liu, Q.; Zhou, Y.; Yang, Z. The cytokine storm of severe influenza and development of immunomodulatory therapy. Cell Mol. Immunol. 2016, 13, 3-10.
18. Edwards, M.R.; Liu, G.; Mire, C.E.; Sureshchandra, S.; Luthra, P.; Yen, B.; Shabman, R.S.; Leung, D.W.; Messaoudi, I.; Geisbert, T.W.; et al. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins. Cell Rep. 2016, 14, 1632-1640.
19. Basler, C.F.; Wang, X.; Mühlberger, E.; Volchkov, V.; Paragas, J.; Klenk, H.D.; García-Sastre, A.; Palese, P. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. USA 2000, 97, 12289-12294.
20. Leung, L.W.; Park, M.-S.; Martinez, O.; Valmas, C.; López, C.B.; Basler, C.F. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells. Immunol. Cell Biol. 2011, 89, 792-802.
21. Reid, S.P.; Valmas, C.; Martinez, O.; Sanchez, F.M.; Basler, C.F. Ebola Virus VP24 Proteins Inhibit the Interaction of NPI-1 Subfamily Karyopherin Proteins with Activated STAT1. J. Virol. 2007, 81, 13469-13477.
22. Martines, R.B.; Ng, D.L.; Greer, P.W.; Rollin, P.E.; Zaki, S.R. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J. Pathol. 2015, 235, 153-174.
23. Basler, C.F.; Mikulasova, A.; Martinez-Sobrido, L.; Paragas, J.; Mühlberger, E.; Bray, M.; Klenk, H.-D.; Palese, P.; García-Sastre, A. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 2003, 77, 7945-7956.
24. Cárdenas, W.B.; Loo, Y.-M.; Gale, M.; Hartman, A.L.; Kimberlin, C.R.; Martínez-Sobrido, L.; Saphire, E.O.; Basler, C.F. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J. Virol. 2006, 80, 5168-5178.
25. Kash, J.C.; Muhlberger, E.; Carter, V.; Grosch, M.; Perwitasari, O.; Proll, S.C.; Thomas, M.J.; Weber, F.; Klenk, H.-D.; Katze, M.G. Global Suppression of the Host Antiviral Response by Ebola- and Marburgviruses: Increased Antagonism of the Type I Interferon Response Is Associated with Enhanced Virulence. J. Virol. 2006, 80, 3009-3020.
26. Morrison, J.; Josset, L.; Tchitchek, N.; Chang, J.; Belser, J.A.; Swayne, D.E.; Pantin-Jackwood, M.J.; Tumpey, T.M.; Katze, M.G. H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in mice. J. Virol. 2014, 88, 10556-10568.
27. Geiss, G.K.; Salvatore, M.; Tumpey, T.M.; Carter, V.S.; Wang, X.; Basler, C.F.; Taubenberger, J.K.; Bumgarner, R.E.; Palese, P.; Katze, M.G.; et al. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl. Acad. Sci. USA 2002, 99, 10736-10741.
28. Holzer, M.; Krahling, V.; Amman, F.; Barth, E.; Bernhart, S.H.; Carmelo, V.A.; Collatz, M.; Doose, G.; Eggenhofer, F.; Ewald, J.; et al. Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells. Sci. Rep. 2016, 6, 34589.
29. Kuzmin, I.V.; Schwarz, T.M.; Ilinykh, P.A.; Jordan, I.; Ksiazek, T.G.; Sachidanandam, R.; Basler, C.F.; Bukreyev, A. Innate Immune Response of Bat and Human Cells to Filoviruses: Commonalities and Distinctions. J. Virol. 2017.
30. Hartman, A.L.; Ling, L.; Nichol, S.T.; Hibberd, M.L. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. J. Virol. 2008, 82, 5348-5358.
31. Hartman, A.L.; Dover, J.E.; Towner, J.S.; Nichol, S.T. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. J. Virol. 2006, 80, 6430-6440.
32. Bosworth, A.; Dowall, S.D.; Garcia-Dorival, I.; Rickett, N.Y.; Bruce, C.B.; Matthews, D.A.; Fang, Y.; Aljabr, W.; Kenny, J.; Nelson, C.; et al. A comparison of host gene expression signatures associated with infection in vitro by the Makona and Ecran (Mayinga) variants of Ebola virus. Sci. Rep. 2017, 7, 43144.
33. Smith, J.R.; Todd, S.; Ashander, L.M.; Charitou, T.; Ma, Y.; Yeh, S.; Crozier, I.; Michael, M.Z.; Appukuttan, B.; Williams, K.A.; et al. Retinal Pigment Epithelial Cells are a Potential Reservoir for Ebola Virus in the Human Eye. Transl. Vis. Sci. Technol. 2017, 6, 12.
34. Geisbert, T.W.; Young, H.A.; Jahrling, P.B.; Davis, K.J.; Kagan, E.; Hensley, L.E. Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event. J. Infect. Dis. 2003, 188, 1618-1629.
35. McElroy, A.K.; Harmon, J.R.; Flietstra, T.D.; Campbell, S.; Mehta, A.K.; Kraft, C.S.; Lyon, M.G.; Varkey, J.B.; Ribner, B.S.; Kratochvil, C.J.; et al. Kinetic analysis of biomarkers in a cohort of us patients with ebola virus disease. Clin. Infect. Dis. 2016, 63, 460-467.
36. Hayman, D.T.S.; Yu, M.; Crameri, G.; Wang, L.-F.; Suu-Ire, R.; Wood, J.L.N.; Cunningham, A.A. Ebola virus antibodies in fruit bats, ghana, west Africa. Emerg. Infect. Dis. 2012, 18, 1207-1209.
37. Towner, J.S.; Amman, B.R.; Sealy, T.K.; Carroll, S.A.R.; Comer, J.A.; Kemp, A.; Swanepoel, R.; Paddock, C.D.; Balinandi, S.; Khristova, M.L.; et al. Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats. PLoS Pathog. 2009, 5, e1000536.
38. Ilinykh, P.A.; Lubaki, N.M.; Widen, S.G.; Renn, L.A.; Theisen, T.C.; Rabin, R.L.; Wood, T.G.; Bukreyev, A. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells. J. Virol. 2015, 89, 7567-7583.
39. Wahl-Jensen, V.; Kurz, S.; Feldmann, F.; Buehler, L.K.; Kindrachuk, J.; DeFilippis, V.; da Silva Correia, J.; Früh, K.; Kuhn, J.H.; Burton, D.R.; et al. Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression. PLoS Negl. Trop. Dis. 2011, 5, e1359.
40. Olejnik, J.; Forero, A.; Deflubé, L.R.; Hume, A.J.; Manhart, W.A.; Nishida, A.; Marzi, A.; Katze, M.G.; Ebihara, H.; Rasmussen, A.L.; et al. Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages. J. Virol. 2017, 91, e00179-17.
41. Bray, M.; Davis, K.; Geisbert, T.; Schmaljohn, C.; Huggins, J. A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever. Source J. Infect. Dis. 1998, 178, 651-661.
42. Dutta, M.; Robertson, S.J.; Okumura, A.; Scott, D.P.; Chang, J.; Weiss, J.M.; Sturdevant, G.L.; Feldmann, F.; Haddock, E.; Chiramel, A.I.; et al. Systems Approach Reveals MAVS Signaling in Myeloid Cells as Critical for Resistance to Ebola Virus in Murine Models of Infection. Cell Rep. 2017, 18, 816-829.
43. Brannan, J.M.; Froude, J.W.; Prugar, L.I.; Bakken, R.R.; Zak, S.E.; Daye, S.P.; Wilhelmsen, C.E.; Dye, J.M. Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease. J. Infect. Dis. 2015, 212, S282-S294.
44. Lüdtke, A.; Oestereich, L.; Ruibal, P.; Wurr, S.; Pallasch, E.; Bockholt, S.; Ip, W.H.; Rieger, T.; Gómez-Medina, S.; Stocking, C.; et al. Ebola Virus Disease in Mice with Transplanted Human Hematopoietic Stem Cells. J. Virol. 2015, 89, 4700-4704.
45. Bird, B.H.; Spengler, J.R.; Chakrabarti, A.K.; Khristova, M.L.; Sealy, T.K.; Coleman-McCray, J.D.; Martin, B.E.; Dodd, K.A.; Goldsmith, C.S.; Sanders, J.; et al. Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease. J. Infect. Dis. 2016, 213, 703-711.
46. Nakayama, E.; Saijo, M. Animal models for Ebola and Marburg virus infections. Front. Microbiol. 2013.
47. Ebihara, H.; Takada, A.; Kobasa, D.; Jones, S.; Neumann, G.; Theriault, S.; Bray, M.; Feldmann, H.; Kawaoka, Y. Molecular Determinants of Ebola Virus Virulence in Mice. PLoS Pathog. 2006, 2, e73.
48. Caballero, I.S.; Honko, A.N.; Gire, S.K.; Winnicki, S.M.; Melé, M.; Gerhardinger, C.; Lin, A.E.; Rinn, J.L.; Sabeti, P.C.; Hensley, L.E.; et al. In Vivo Ebola virus infection leads to a strong innate response in circulating immune cells. BMC Genom. 2016.
49. Sanchez, A.; Lukwiya, M.; Bausch, D.; Mahanty, S.; Sanchez, A.J.; Wagoner, K.D.; Rollin, P.E. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: Cellular responses, virus load, and nitric oxide levels. J. Virol. 2004, 78, 10370-10377.
50. Fisher-Hoch, S.P.; Lloyd, G.; Platt, G.S.; Simpson, D.I.H.; Neild, G.H.; Barrett, A.J. Haematological and biochemical monitoring of ebola infection in rhesus monkeys: implications for patient management. Lancet 1983, 322, 1055-1058.
51. Rasmussen, A.L.; Okumura, A.; Ferris, M.T.; Green, R.; Feldmann, F.; Kelly, S.M.; Scott, D.P.; Safronetz, D.; Haddock, E.; LaCasse, R.; et al. Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance. Science 2014.
52. Churchill, G.A.; Airey, D.C.; Allayee, H.; Angel, J.M.; Attie, A.D.; Beatty, J.; Beavis, W.D.; Belknap, J.K.; Bennett, B.; Berrettini, W.; et al. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat. Genet. 2004, 36, 1133-1137.
53. Cilloniz, C.; Ebihara, H.; Ni, C.; Neumann, G.; Korth, M.J.; Kelly, S.M.; Kawaoka, Y.; Feldmann, H.; Katze, M.G. Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. J. Virol. 2011, 85, 9060-9068.
54. Panchal, R.G.; Bradfute, S.B.; Peyser, B.D.; Warfield, K.L.; Ruthel, G.; Lane, D.; Kenny, T.A.; Anderson, A.O.; Raschke, W.C.; Bavari, S. Reduced Levels of Protein Tyrosine Phosphatase CD45 Protect Mice from the Lethal Effects of Ebola Virus Infection. Cell Host Microbe 2009, 6, 162-173.
55. Bradfute, S.B.; Warfield, K.L.; Bray, M. Mouse models for filovirus infections. Viruses 2012, 4, 1477-1508.
56. Warfield, K.L.; Perkins, J.G.; Swenson, D.L.; Deal, E.M.; Bosio, C.M.; Aman, M.J.; Yokoyama, W.M.; Young, H.A.; Bavari, S. Role of natural killer cells in innate protection against lethal ebola virus infection. J. Exp. Med. 2004, 200, 169-179.
57. Cimini, E.; Viola, D.; Cabeza-Cabrerizo, M.; Romanelli, A.; Tumino, N.; Sacchi, A.; Bordoni, V.; Casetti, R.; Turchi, F.; Martini, F.; et al. Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections. PLoS Negl. Trop. Dis. 2017, 11, e0005645.
58. Larsen, T.; Stevens, E.L.; Davis, K.J.; Geisbert, J.B.; Daddario-DiCaprio, K.M.; Jahrling, P.B.; Hensley, L.E.; Geisbert, T.W. Pathologic Findings Associated with Delayed Death in Nonhuman Primates Experimentally Infected with Zaire Ebola Virus. J. Infect. Dis. 2007, 196, S323-S328.
59. Zeng, X.; Blancett, C.D.; Koistinen, K.A.; Schellhase, C.W.; Bearss, J.J.; Radoshitzky, S.R.; Honnold, S.P.; Chance, T.B.; Warren, T.K.; Froude, J.W.; et al. Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nat. Microbiol. 2017, 2, 17113.
60. Shantha, J.G.; Yeh, S.; Nguyen, Q.D. Ebola virus disease and the eye. Curr. Opin. Ophthalmol. 2016, 27, 538-544.
61. Billioux, B.J.; Smith, B.; Nath, A. Neurological Complications of Ebola Virus Infection. Neurotherapeutics 2016, 13, 461-470.
62. Lee, A.; Khiabanian, H.; Kugelman, J.; Elliott, O.; Nagle, E.; Yu, G.-Y.; Warren, T.; Palacios, G.; Rabadan, R. Transcriptome reconstruction and annotation of cynomolgus and African green monkey. BMC Genom. 2014, 15, 846.
63. Peng, X.; Thierry-Mieg, J.; Thierry-Mieg, D.; Nishida, A.; Pipes, L.; Bozinoski, M.; Thomas, M.J.; Kelly, S.; Weiss, J.M.; Raveendran, M.; et al. Tissue-specific transcriptome sequencing analysis expands the non-human primate reference transcriptome resource (NHPRTR). Nucleic Acids Res. 2015, 43, D737-D742.
64. Zimin, A.V.; Cornish, A.S.; Maudhoo, M.D.; Gibbs, R.M.; Zhang, X.; Pandey, S.; Meehan, D.T.; Wipfler, K.; Bosinger, S.E.; Johnson, Z.P.; et al. A new rhesus macaque assembly and annotation for next-generation sequencing analyses. Biol. Direct. 2014, 9, 20.
65. Rubins, K.H.; Hensley, L.E.; Wahl-Jensen, V.; Daddario DiCaprio, K.M.; Young, H.A.; Reed, D.S.; Jahrling, P.B.; Brown, P.O.; Relman, D.A.; Geisbert, T.W. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol. 2007.
66. Yen, J.Y.; Garamszegi, S.; Geisbert, J.B.; Rubins, K.H.; Geisbert, T.W.; Honko, A.; Xia, Y.; Connor, J.H.; Hensley, L.E. Therapeutics of Ebola hemorrhagic fever: Whole-genome transcriptional analysis of successful disease mitigation. J. Infect. Dis. 2011.
67. Menicucci, A.R.; Sureshchandra, S.; Marzi, A.; Feldmann, H.; Messaoudi, I. Transcriptomic analysis reveals a previously unknown role for CD8(+) T-cells in rVSV-EBOV mediated protection. Sci. Rep. 2017, 7, 919.
68. Zaas, A.K.; Chen, M.; Varkey, J.; Veldman, T.; Hero, A.O.; Lucas, J.; Huang, Y.; Turner, R.; Gilbert, A.; Lambkin-Williams, R.; et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 2009.
69. Woods, C.W.; McClain, M.T.; Chen, M.; Zaas, A.K.; Nicholson, B.P.; Varkey, J.; Veldman, T.; Kingsmore, S.F.; Huang, Y.; Lambkin-Williams, R.; et al. Host Transcriptional Signature for Presymptomatic Detection of Infection in Humans Exposed to Influenza H1N1 or H3N2. PLoS ONE 2013.
70. Kobasa, D.; Jones, S.M.; Shinya, K.; Kash, J.C.; Copps, J.; Ebihara, H.; Hatta, Y.; Hyun, K.J.; Halfmann, P.; Hatta, M.; et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007, 445, 319-323.
71. Caballero, I.S.; Yen, J.Y.; Hensley, L.E.; Honko, A.N.; Goff, A.J.; Connor, J.H. Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection. BMC Genom. 2014, 15, 1-12.
72. Connor, J.H.; Yen, J.; Caballero, I.S.; Garamszegi, S.; Malhotra, S.; Lin, K.; Hensley, L.; Goff, A.J. Transcriptional Profiling of the Immune Response to Marburg Virus Infection. J. Virol. 2015, 89, 9865-9874.
73. Malhotra, S.; Yen, J.Y.; Honko, A.N.; Garamszegi, S.; Caballero, I.S.; Johnson, J.C.; Mucker, E.M.; Trefry, J.C.; Hensley, L.E.; Connor, J.H. Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure. PLoS Negl. Trop. Dis. 2013, 7, e2171.
74. Garamszegi, S.; Yen, J.Y.; Honko, A.N.; Geisbert, J.B.; Rubins, K.H.; Geisbert, T.W.; Xia, Y.; Hensley, L.E.; Connor, J.H. Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus. PLoS Negl. Trop. Dis. 2014, 8, e3061.
75. Rhein, B.A.; Powers, L.S.; Rogers, K.; Anantpadma, M.; Singh, B.K.; Sakurai, Y.; Bair, T.; Miller-Hunt, C.; Sinn, P.; Davey, R.A.; et al. Interferon-γ Inhibits Ebola Virus Infection. PLoS Pathog. 2015, 11, e1005263.
76. Gupta, M.; Greer, P.; Mahanty, S.; Shieh, W.-J.; Zaki, S.R.; Ahmed, R.; Rollin, P.E. CD8-Mediated Protection against Ebola Virus Infection Is Perforin Dependent. J. Immunol. 2005, 174, 4198-4202.
77. Jones, S.M.; Feldmann, H.; Stroher, U.; Geisbert, J.B.; Fernando, L.; Grolla, A.; Klenk, H.D.; Sullivan, N.J.; Volchkov, V.E.; Fritz, E.A.; et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med. 2005, 11.
78. Geisbert, T.W.; Feldmann, H. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J. Infect. Dis. 2011, 204, S1075-S1081.
79. Marzi, A.; Feldmann, H.; Geisbert, T.W.; Falzarano, D. Vesicular Stomatitis Virus-Based Vaccines for Prophylaxis and Treatment of Filovirus Infections. J. Bioterror. Biodef. 2011.
80. Henao-Restrepo, A.M.; Camacho, A.; Longini, I.M.; Watson, C.H.; Edmunds, W.J.; Egger, M.; Carroll, M.W.; Dean, N.E.; Diatta, I.; Doumbia, M.; et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 2017, 389, 505-518.
81. Barrenas, F.; Green, R.R.; Thomas, M.J.; Law, G.L.; Proll, S.C.; Engelmann, F.; Messaoudi, I.; Marzi, A.; Feldmann, H.; Katze, M.G. Next generation sequencing reveals a controlled immune response to Zaire Ebola virus challenge in cynomolgus macaques immunized with VSVΔG/EBOVgp. Clin. Vaccine Immunol. 2015.
82. Liu, X.; Speranza, E.; Muñoz-Fontela, C.; Haldenby, S.; Rickett, N.Y.; Garcia-Dorival, I.; Fang, Y.; Hall, Y.; Zekeng, E.-G.; Lüdtke, A.; et al. Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus. Genome Biol. 2017, 18, 4.
83. Kash, J.C.; Walters, K.-A.; Kindrachuk, J.; Baxter, D.; Scherler, K.; Janosko, K.B.; Adams, R.D.; Herbert, A.S.; James, R.M.; Stonier, S.W.; et al. Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease. Sci. Transl. Med. 2017.
84. Ellebedy, A.H.; Jackson, K.J.L.; Kissick, H.T.; Nakaya, H.I.; Davis, C.W.; Roskin, K.M.; McElroy, A.K.; Oshansky, C.M.; Elbein, R.; Thomas, S.; et al. Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination. Nat. Immunol. 2016, 17, 1226-1234.
85. Duy, J.; Koehler, J.W.; Honko, A.N.; Schoepp, R.J.; Wauquier, N.; Gonzalez, J.-P.; Pitt, M.L.; Mucker, E.M.; Johnson, J.C.; O’Hearn, A.; et al. Circulating microRNA profiles of Ebola virus infection. Sci. Rep. 2016, 6, 24496.
86. Smith, L.M.; Hensley, L.E.; Geisbert, T.W.; Johnson, J.; Stossel, A.; Honko, A.; Yen, J.Y.; Geisbert, J.; Paragas, J.; Fritz, E.; et al. Interferon-β Therapy Prolongs Survival in Rhesus Macaque Models of Ebola and Marburg Hemorrhagic Fever. J. Infect. Dis. 2013, 208, 310-318.
87. Konde, M.K.; Baker, D.P.; Traore, F.A.; Sow, M.S.; Camara, A.; Barry, A.A.; Mara, D.; Barry, A.; Cone, M.; Kaba, I.; et al. Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial. PLoS ONE 2017, 12, e0169255.
88. Broadhurst, M.J.; Brooks, T.J.G.; Pollock, N.R. Diagnosis of Ebola Virus Disease: Past, Present, and Future. Clin. Microbiol. Rev. 2016, 29, 773-793.
89. Tsalik, E.L.; Henao, R.; Nichols, M.; Burke, T.; Ko, E.R.; McClain, M.T.; Hudson, L.L.; Mazur, A.; Freeman, D.H.; Veldman, T.; et al. Host gene expression classifiers diagnose acute respiratory illness etiology. Sci. Transl. Med. 2016.
90. Sampson, D.L.; Fox, B.A.; Yager, T.D.; Bhide, S.; Cermelli, S.; McHugh, L.C.; Seldon, T.A.; Brandon, R.A.; Sullivan, E.; Zimmerman, J.J.; et al. A Four-Biomarker Blood Signature Discriminates Systemic Inflammation Due to Viral Infection Versus Other Etiologies. Sci. Rep. 2017.
91. Navalkar, K.; Kim, T.-K.; Gelinas, R. Pre-Symptomatic Diagnosis of Ebola Virus Infection. J. Emerg. Virol. Dis. 2013, 3.
92. Scott, J.T.; Sesay, F.R.; Massaquoi, T.A.; Idriss, B.R.; Sahr, F.; Semple, M.G. Post-Ebola Syndrome, Sierra Leone. Emerg. Infect. Dis. 2016, 22, 641-646.
93. Varkey, J.B.; Shantha, J.G.; Crozier, I.; Kraft, C.S.; Lyon, G.M.; Mehta, A.K.; Kumar, G.; Smith, J.R.; Kainulainen, M.H.; Whitmer, S.; et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. N. Engl. J. Med. 2015, 372, 2423-2427.